Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[¹⁸F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular Inflammation

Background: Immune checkpoint inhibitors (ICI) are one of the most effective therapies in oncology, albeit associated with various immune-related adverse events also affecting the cardiovascular system. Methods: We aimed to investigate the effect of ICI on arterial 2-[¹⁸F]FDG uptake by us...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Raffaella Calabretta, Lucian Beer, Helmut Prosch, Daria Kifjak, Lucia Zisser, Patrick Binder, Stefan Grünert, Werner Langsteger, Xiang Li, Marcus Hacker
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2024-01-01
Rangatū:	Life
Ngā marau:	atherosclerosis immune checkpoint inhibitors PET 2-[<sup>18</sup>F]FDG lung cancer cardio-oncology
Urunga tuihono:	https://www.mdpi.com/2075-1729/14/1/146
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!